Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPRF | P10586 | 10/20 | 0.32 |
| ▸ | PTPN2 | P17706 | 10/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 10/20 | 0.32 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18090056 | 0.96 | PTPRF (0.30) | PTPRFPTPN2PTPN1NPC1MAPT | |
| SCHEMBL18090053 | 0.96 | PTPRF (0.30) | PTPRFPTPN2PTPN1NPC1MAPT | |
| SCHEMBL18090007 | 0.91 | PTPRF (0.32) | PTPRFPTPN2PTPN1LIMK1 | |
| SCHEMBL18089994 | 0.91 | LIMK1 (0.34) | PTPRFPTPN2PTPN1LIMK1NPC1 | |
| SCHEMBL18090101 | 0.90 | ALOX5 (0.30) | — | |
| SCHEMBL18090105 | 0.90 | NPC1 (0.33) | PTPRFPTPN2PTPN1NPC1MAPT | |
| SCHEMBL18089921 | 0.89 | NPC1 (0.36) | PTPRFPTPN2PTPN1NPC1MAPT | |
| SCHEMBL18090045 | 0.88 | NPC1 (0.33) | PTPRFPTPN2PTPN1LIMK1NPC1 | |
| SCHEMBL18089996 | 0.86 | ALOX5 (0.44) | PTPRFPTPN2PTPN1LIMK1 | |
| SCHEMBL18090004 | 0.84 | LIMK1 (0.31) | LIMK1NPC1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9780316-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2017-10-03 | — | — | US | disclosed |
| US-9780316-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2017-10-03 | — | — | US | disclosed |
| US-20160276604-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-09-22 | — | — | US | disclosed |
| US-20160276604-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-09-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160276604-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | RB1, LEF1, BRD1 | PTPRF 4540/4885PTPN2 3931/4885PTPN1 4043/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.